Additional information
Notes on contributors
Robert A. Figlin
Robert A. Figlin, MD, FACP, is Steven Spielberg Family Chair in Hematology Oncology; professor of medicine and biomedical sciences; director, Division of Hematology Oncology; deputy director, Integrated Oncology Service Line; deputy director, Samuel Oschin Comprehensive Cancer Institute, Cedars‐Sinai Medical Center, New York, N.Y. Jocelyn Mohs, PharmD, BCOP, is pharmacy supervisor, Infusion Clinic Pharmacy, Sanford Roger Maris Cancer Center, Fargo, N.D. Laura S. Wood, RN, MSN, OCN, is renal cancer research coordinator, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.
Jocelyn Mohs
Robert A. Figlin, MD, FACP, is Steven Spielberg Family Chair in Hematology Oncology; professor of medicine and biomedical sciences; director, Division of Hematology Oncology; deputy director, Integrated Oncology Service Line; deputy director, Samuel Oschin Comprehensive Cancer Institute, Cedars‐Sinai Medical Center, New York, N.Y. Jocelyn Mohs, PharmD, BCOP, is pharmacy supervisor, Infusion Clinic Pharmacy, Sanford Roger Maris Cancer Center, Fargo, N.D. Laura S. Wood, RN, MSN, OCN, is renal cancer research coordinator, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.
Laura S. Wood
Robert A. Figlin, MD, FACP, is Steven Spielberg Family Chair in Hematology Oncology; professor of medicine and biomedical sciences; director, Division of Hematology Oncology; deputy director, Integrated Oncology Service Line; deputy director, Samuel Oschin Comprehensive Cancer Institute, Cedars‐Sinai Medical Center, New York, N.Y. Jocelyn Mohs, PharmD, BCOP, is pharmacy supervisor, Infusion Clinic Pharmacy, Sanford Roger Maris Cancer Center, Fargo, N.D. Laura S. Wood, RN, MSN, OCN, is renal cancer research coordinator, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.